Generic combination drugs save money but may contain different inactive ingredients than brand versions. For some patients-especially those on narrow therapeutic index drugs-these differences can affect effectiveness or cause side effects. Here’s what you need to know.
Fluoroquinolones like levofloxacin can trigger sudden delirium in older adults, causing confusion, hallucinations, and memory loss. Learn the signs, risks, and safer alternatives to protect elderly patients.
ACE inhibitors and ARBs both treat high blood pressure and kidney disease, but combining them increases risks without benefits. Learn why doctors avoid this combo and what safer alternatives exist.
Autoimmune overlap syndromes like AIH-PBC occur when the immune system attacks the liver in multiple ways at once. Learn how PBC, PSC, and AIH combine, why diagnosis is tricky, and what treatments actually work.
Debunking common medication safety myths with facts backed by science and real patient data. Learn why OTC drugs aren't always safe, why you must finish antibiotics, and how to avoid dangerous interactions.
Direct-acting antivirals cure over 95% of hepatitis C cases with just 8-12 weeks of oral pills. Learn how these treatments work, why cure rates are so high, and why so many people still aren't getting treated.
Many medications cause halos and light sensitivity-some can lead to permanent eye damage. Learn which drugs are risky, how to spot early signs, and what steps to take to protect your vision before it's too late.
Learn how drug-drug interactions work, including pharmacokinetic and pharmacodynamic mechanisms, common high-risk combinations, and how to protect yourself from dangerous side effects.
Learn how to accurately document drug allergies in your medical records to prevent dangerous medication errors. Know what details to include, why vague entries are risky, and how to ensure your records keep you safe.
Biologic therapy has transformed Crohn’s disease management by targeting inflammation at its source. Learn how anti-TNF drugs, vedolizumab, and ustekinumab work, their real-world benefits, risks, and how to stay on track for long-term remission.
